SCHEMBL23933986

SCHEMBL23933986

Cc1ccc2cccc(NS(=O)(=O)c3ccc(C#N)cc3)c2n1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.74
TDP1 Q9NUW8 2/20 0.74
MEN1 O00255 1/20 0.74
SLC40A1 Q9NP59 6/20 0.72
GLO1 Q04760 4/20 0.72
AGTR1 P30556 2/20 0.72
PAX8 Q06710 1/20 0.72
NFKBIA P25963 5/20 0.60
RELA Q04206 5/20 0.60
HSD11B1 P28845 3/20 0.59
MITF O75030 1/20 0.53
S1PR4 O95977 1/20 0.53
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
MAPT P10636 1/20 0.53
S1PR1 P21453 1/20 0.53
OPRK1 P41145 1/20 0.53
HTT P42858 1/20 0.53
CKS1B P61024 1/20 0.53
SKP2 Q13309 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26053588 0.85 KMT2A (1.00) KMT2ATDP1MEN1SLC40A1GLO1
SCHEMBL6984645 0.84 SLC40A1 (1.00) KMT2ATDP1MEN1SLC40A1GLO1
SCHEMBL30925511 0.82 GLO1 (1.00) KMT2ATDP1MEN1SLC40A1GLO1
SCHEMBL13486175 0.82 GLO1 (1.00) KMT2ATDP1MEN1SLC40A1GLO1
SCHEMBL22764828 0.82 GLO1 (0.61) KMT2ATDP1MEN1SLC40A1GLO1
SCHEMBL30471549 0.82 GLO1 (0.61) KMT2ATDP1MEN1SLC40A1GLO1
SCHEMBL23934034 0.81 KMT2A (0.76) KMT2ATDP1MEN1SLC40A1GLO1
SCHEMBL23934032 0.81 KMT2A (0.76) KMT2ATDP1MEN1SLC40A1GLO1
SCHEMBL23933988 0.81 TDP1 (0.71) KMT2ATDP1MEN1SLC40A1GLO1
SCHEMBL22578645 0.80 KMT2A (0.74) KMT2ATDP1MEN1SLC40A1GLO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210323924-A1 QUINOLINE SULFONAMIDES USEFUL TO TREAT DISEASE DAHL RUSSELL (US) 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323924-A1 QUINOLINE SULFONAMIDES USEFUL TO TREAT DISEASE CLN6, NDUFS3, NDUFS2 KMT2A 2019/4885TDP1 662/4885MEN1 2804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.